Catalyst Wire Dossier Catalyst Wire Dossier

ZP-Zolmitriptan

zolmitriptan · Zosano Pharma Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZP-Zolmitriptan, covering 2018-02-14 to 2018-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine [Phase 2, Phase 3]

See pricing